Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing...

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.

News | November 06, 2019

November 6, 2019 — Cleveland Clinic announced the Top 10...

Medtronic Initiates Worldwide Pivotal Study of Extravascular Implantable Cardioverter Defibrillator
News | Implantable Cardioverter Defibrillator (ICD) | October 11, 2019

October 11, 2019 — Medtronic plc announced the start of a worldwide pivotal study evaluating its investigational...

Early ICD Use Prolongs Survival After Coronary Stenting
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019

September 18, 2019 — Early use of an...

Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019

July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...

The Zoll Lifevest Wearable External Defibrillator Offers a Bridge Therapy and buys time for physicians to determine if an implantable defibrillator is needed.
News | Sudden Cardiac Arrest | July 02, 2019

For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable...

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD) | May 24, 2019 | Dave Fornell, Editor

This is a brief overview of updates on...

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019

May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...

Studies Find Race and Gender Disparities in Implantable Heart Devices
News | EP Lab | May 15, 2019

May 15, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices,...

Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019

May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs),...

Emblem Subcutaneous ICD Safe and Effective for Majority of Patients
News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019

May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of...

News | EP Lab | May 13, 2019

May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...

A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system showed it can be implanted with no major complications, and can sense, pace and defibrillate the heart.

Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.

News | May 13, 2019

May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter...

Biotronik Launches Acticor DX and CRT-DX Devices in U.S.
News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX...

Overlay Init